Business Context and Reporting Period
This Form 8-K is a current report filed by OncoCyte Corporation (not Insight Molecular Diagnostics Inc.) on August 14, 2018. The filing serves to announce the company's financial results for the three and six months ended June 30, 2018. The detailed results are contained in a press release attached as Exhibit 99.1.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is incorporated by reference but not included in the provided text.
Material Changes
No specific material changes versus prior periods are quantified in the body of this 8-K. The document directs readers to the press release for the comparison of results for the three and six months ended June 30, 2018.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The filing includes a standard disclaimer that statements containing words such as "may," "will," "believes," or "expects" are forward-looking and subject to risks.
- Risk Factors: The company directs investors to the "Risk Factors" section of its most recent Form 10-K and Form 10-Q for additional factors that could cause actual results to differ materially from anticipated results.
- Emerging Growth Company: OncoCyte Corporation has indicated it is an emerging growth company.
- Outlook: No specific financial guidance or outlook numbers are provided in this text.
Investor Verification Checklist
- Verify the specific revenue and net loss figures for the three and six months ended June 30, 2018, by reviewing the attached Exhibit 99.1 (Press Release).
- Confirm the company's cash position and burn rate from the press release to assess liquidity runway.
- Review the most recent Form 10-K and 10-Q for detailed risk factors referenced in this filing.
- Note that the registrant name in the filing is OncoCyte Corporation, distinct from the name provided in the request metadata.